The Surgical Robotics Revolution Isn't Slowing Down Any Time soon, Says RBC Analyst

  • Brandon Henry of RBC Capital Markets estimated that US robotic general surgery volumes rose sequentially in the third quarter.
  • Henry noted that around 93 percent of US robotic surgeons he surveyed indicated their third quarter robotic volumes were flat or up sequentially.
  • Henry added his survey bodes well for Intuitive Surgical, Inc. ISRG despite the da Vinci Xi still in its early product lifecycle.
According to Brandon Henry of RBC Capital Markets, US robotic general surgery volumes are likely to be higher sequentially in the third quarter. The analyst noted that 93 percent of US robotic general surgeons he surveyed expect their third quarter robotic volumes to be flat or up sequentially – a finding that is consistent with checks at the American College of Surgeons annual meeting. Henry continued that his survey and checks bodes well for Intuitive Surgical as the company should show an approximate two percent sequential growth and 35 percent year over year growth its US general surgery procedures despite its da Vinci Xi still in its early product cycle. The analyst added that the surgeons he surveyed expect the number of Xi systems within their areas of practice to increase by 50 percent over the next 12 months. Moreover, the majority of robotic surgeons are "quite satisfied" with Intuitive Surgical's robotics offerings. Intuitive Surgical is scheduled to report its third quarter results on Tuesday, October 20, after market close. The analyst is modeling 121 worldwide da Vinci system placements and an approximate 14 percent worldwide procedure growth as the entire sector benefited from "stable worldwide hospital capital spending trends." Looking forward to 2016, Henry's survey indicated that surgeons are expecting their robotic general surgery procedures to grow approximately 35 percent year over year – a figure that is "slightly above" the analyst's own estimate for Intuitive Surgical of 30 percent which offers confidence the company can achieve at least his growth targets. Shares of Intuitive Surgical remain Sector Perform rated with an unchanged $565 price target.

Posted In: Brandon Henryda Vinci XiRBC Capital MarketsRobotic SurgeryAnalyst ColorAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.